Loading stock data…
MET
$77.84-0.24 (-0.30%)
Market OpenUpdated 3:52 PM EDT
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
MetLife, Inc. in the Financial Services sector is trading at $77.84. The stock is currently 7% below its 52-week high of $83.85, remaining 1.3% above its 200-day moving average. Technical signals show neutral RSI of 52 and bearish MACD signal, explaining why MET maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$77.84
Potential Upside
28.6%
Whystock Fair Value$100.13
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus16 analysts
Buy
Mean target$90.25+15.9%
Range$75.00 – $106.00
Fundamentals
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Mid...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$50.71B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.34
Beta
Defensive asset. Lower volatility than the S&P 500.
0.73
Div Yield
Strong income play. Yield provides a meaningful total return floor.
293.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.10%
Volume
Today's trading volume
2.17M
Recent News
Assessing MetLife (MET) Valuation After Recent Share Price Moves And Long Term Returns
MetLife stock snapshot and recent performance MetLife (MET) is drawing attention after a recent move in its share price, with the stock closing at $78.82. Investors are weighing this level against its recent returns and current fundamentals. See our latest analysis for MetLife. The recent 1-day share price decline of 1.67% and 7-day share price return of 1.60% sit against a stronger 30-day share price return of 10.70%. Meanwhile, the 3-year total shareholder return of 67.22% and 5-year total...
MET Tops Q1 EPS Estimates on Strong Investment Income and Volume Growth
MetLife posts a Q1 earnings beat as investment income, underwriting gains and strong segment growth lift profits and revenues.
MetLife, Inc. Q1 2026 Earnings Call Summary
Moby summary of MetLife, Inc.'s Q1 2026 earnings call
MetLife (MET) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MetLife (NYSE:MET) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
Global insurance giant MetLife (NYSE:MET) fell short of the market’s revenue expectations in Q1 CY2026 as sales only rose 1.3% year on year to $19.07 billion. Its non-GAAP profit of $2.42 per share was 6.6% above analysts’ consensus estimates.